Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...

Steve Jobs succumbed to a rare pancreatic neuroendocrine tumor. This cancer type differs significantly from common pancreatic ...

Liver cancer often goes undetected; awareness, early diagnosis, and prevention are crucial for improving outcomes and saving lives.

A CANCER that creeps up quietly, spotted when it’s too late – 60 per cent of patients will die within a year of their ...

Actress Dipika Kakar revealed her liver cancer diagnosis during her Diwali celebration vlog, sharing that she is experiencing ...

Saadat’s story is an example of how proper care can help individuals live full lives with CHB. But for every success story ...

Dr Basant highlights the growing liver cancer threat in India, primarily from lifestyle choices. He advocates for adopting habits to enhance liver health.

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

Merck and Eisai halt late-stage trial as Keytruda/Lenvima combo fails to improve survival in liver cancer. Read more here.

A health insurance dispute is preventing a North Carolina man from getting a cancer drug his doctors say is necessary.